Lee Ann Lawson

875 total citations
17 papers, 691 citations indexed

About

Lee Ann Lawson is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Lee Ann Lawson has authored 17 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Lee Ann Lawson's work include Lysosomal Storage Disorders Research (10 papers), Child Nutrition and Feeding Issues (5 papers) and Neurogenetic and Muscular Disorders Research (5 papers). Lee Ann Lawson is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Child Nutrition and Feeding Issues (5 papers) and Neurogenetic and Muscular Disorders Research (5 papers). Lee Ann Lawson collaborates with scholars based in United States, Sweden and Slovakia. Lee Ann Lawson's co-authors include Barry J. Byrne, Barbara K. Smith, David D. Fuller, Manuela Corti, Shelley Collins, Saleem Islam, Thomas J. Conlon, Nathalie Clément, Darin J. Falk and Sushrusha Nayak and has published in prestigious journals such as Human Molecular Genetics, The Journal of Pediatrics and Experimental Neurology.

In The Last Decade

Lee Ann Lawson

16 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lee Ann Lawson United States	11	361	297	249	161	110	17	691
Shelley Collins United States	9	246 0.7×	198 0.7×	149 0.6×	103 0.6×	84 0.8×	13	453
Denise A Cloutier United States	7	299 0.8×	212 0.7×	184 0.7×	127 0.8×	101 0.9×	7	488
Paula Goldenberg United States	11	258 0.7×	571 1.9×	307 1.2×	126 0.8×	370 3.4×	24	957
Sara Marcó Spain	11	368 1.0×	239 0.8×	240 1.0×	36 0.2×	148 1.3×	14	580
Sean N. Prater United States	12	720 2.0×	167 0.6×	76 0.3×	392 2.4×	235 2.1×	19	875
Elizabeth Spellacy United Kingdom	14	298 0.8×	208 0.7×	71 0.3×	127 0.8×	132 1.2×	19	604
Suhrad G. Banugaria United States	16	1.0k 2.8×	222 0.7×	105 0.4×	574 3.6×	304 2.8×	26	1.2k
Ali Reza Tavasoli Iran	15	106 0.3×	306 1.0×	73 0.3×	38 0.2×	64 0.6×	109	696
Daniel J. Rowan United States	10	284 0.8×	67 0.2×	45 0.2×	97 0.6×	151 1.4×	30	523
Marina Stroppiano Italy	17	634 1.8×	271 0.9×	58 0.2×	181 1.1×	210 1.9×	34	822

Countries citing papers authored by Lee Ann Lawson

Since Specialization

Citations

This map shows the geographic impact of Lee Ann Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Ann Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Ann Lawson more than expected).

Fields of papers citing papers by Lee Ann Lawson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Ann Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Ann Lawson. The network helps show where Lee Ann Lawson may publish in the future.

Co-authorship network of co-authors of Lee Ann Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Ann Lawson. A scholar is included among the top collaborators of Lee Ann Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Ann Lawson. Lee Ann Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ramaswami, Uma, Esperanza Font–Montgomery, Özlem Göker-Alpan, et al.. (2025). Safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from ASPIRE, a phase 3b, open-label, single-arm, 12-month clinical trial, and its open-label extension. Molecular Genetics and Metabolism. 145(1). 109102–109102. 3 indexed citations

Langaee, Taimour, Richard E. Wagner, Lloyd P. Horne, et al.. (2018). Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping Assay. Genetic Testing and Molecular Biomarkers. 22(4). 266–269. 9 indexed citations

Corti, Manuela, Barbara K. Smith, Lee Ann Lawson, et al.. (2017). Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV- hGAA ) Gene Therapy in Children Affected by Pompe Disease. PubMed. 28(4). 208–218. 90 indexed citations

Stacpoole, Peter W., Jonathan J. Shuster, John L.P. Thompson, et al.. (2017). Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trial. Mitochondrion. 42. 59–63. 12 indexed citations

Smith, Barbara K., A. Daniel Martin, Lee Ann Lawson, et al.. (2016). Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity. Experimental Neurology. 287(Pt 2). 216–224. 35 indexed citations

Smith, Barbara K., David D. Fuller, A. Daniel Martin, et al.. (2016). Diaphragm Pacing as a Rehabilitative Tool for Patients With Pompe Disease Who Are Ventilator-Dependent: Case Series. Physical Therapy. 96(5). 696–703. 18 indexed citations

Smith, Barbara K., et al.. (2015). Respiratory motor function in individuals with centronuclear myopathies. Muscle & Nerve. 53(2). 214–221. 4 indexed citations

Byrne, Barry J., Barbara K. Smith, Cathryn Mah, et al.. (2014). Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease. PubMed. 25(3). 134–163. 34 indexed citations

Corti, Manuela, Lee Ann Lawson, Sushrusha Nayak, et al.. (2014). B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study. Molecular Therapy — Methods & Clinical Development. 1. 14033–14033. 111 indexed citations

10.

Doerfler, Phillip A., et al.. (2014). Pharmacological chaperones prevent the precipitation of rhGAA by anti-GAA antibodies during enzyme replacement therapy. Molecular Genetics and Metabolism. 111(2). S38–S38. 1 indexed citations

11.

Corti, Manuela, Barbara K. Smith, Darin J. Falk, et al.. (2014). Altered activation of the tibialis anterior in individuals with Pompe disease: Implications for motor unit dysfunction. Muscle & Nerve. 51(6). 877–883. 18 indexed citations

12.

Fuller, David D., Mai K. ElMallah, Barbara K. Smith, et al.. (2013). The respiratory neuromuscular system in Pompe disease. Respiratory Physiology & Neurobiology. 189(2). 241–249. 93 indexed citations

13.

Elder, Melissa E., Sushrusha Nayak, Shelley Collins, et al.. (2013). B-Cell Depletion and Immunomodulation before Initiation of Enzyme Replacement Therapy Blocks the Immune Response to Acid Alpha-Glucosidase in Infantile-Onset Pompe Disease. The Journal of Pediatrics. 163(3). 847–854.e1. 62 indexed citations

14.

Smith, Barbara K., Shelley Collins, Thomas J. Conlon, et al.. (2013). Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes. Human Gene Therapy. 24(6). 630–640. 127 indexed citations

15.

Fuller, David D., Mai K. ElMallah, Darin J. Falk, et al.. (2013). The importance of targeting the central nervous system for treatment of respiratory insufficiency in Pompe disease. Molecular Genetics and Metabolism. 108(2). S41–S41. 1 indexed citations

16.

Byrne, Barry J., Barbara K. Smith, Cathryn Mah, et al.. (2012). Phase I/II Trial of Adeno-associated Virus Acid-alpha-Glucosidase (AAV-GAA) Diaphragm Gene Therapy for Ventilatory Failure in Pompe Disease. Molecular Genetics and Metabolism. 105(2). S24–S24. 1 indexed citations

17.

Byrne, Barry J., Darin J. Falk, Christina A. Pacak, et al.. (2011). Pompe disease gene therapy. Human Molecular Genetics. 20(R1). R61–R68. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact